Trial
NCT03582085
Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Fibromyalgia
Intervention
Bacillus Calmette Guerin Vaccine
Why stopped
No funding at the current time.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-21